| 产品详情 |
| Edit |   |
|---|
| Product Name | ML-191 |
|---|
| Description | Purity >98%. GPR55 is a G protein-coupled receptor that has been described as a cannabinoid (CB) receptor, although it also responds to other ligands, including lysophosphatidylinositol (LPI). ML-191 is an antagonist of GPR55, blocking LPI-induced activation (EC50 = 1.1 µM). ML-191 inhibits LPI-induced phosphorylation of ERK1/2 (IC50 = 328 nM) and blocks receptor-dependent translocation of PKCBetaII when used at a concentration of 30 µM. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 5-phenyl-3-(1-(1-(p- tolyl)cyclopropane-1-carbonyl)piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one, CCG-152883, CID-23612552 |
|---|
| Gene, Accession, CAS # | CAS: 931695-79-3 |
|---|
| Catalog # | LS-H8734 |
|---|
| Price | |
|---|
| Order / More Info | ML-191 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|